Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1970 Oct;6(4):406–413. doi: 10.1128/jvi.6.4.406-413.1970

Soluble Components of Adenovirus Type 8 1

Anna Lengyel 1, István Nász 1
PMCID: PMC376137  PMID: 5497886

Abstract

Soluble components of type 8 adenovirus have been studied. Four different components were isolated by anion-exchange chromatography and purified by further chromatographic procedures, by zonal centrifugation, and by erythrocyte absorption and elution. The four components exhibited the following characteristics. (i) Fiber antigen was trypsin-resistant and functioned as incomplete hemagglutinin (agglutinated rat and human erythrocytes only in the presence of certain types of adenovirus antisera). (ii) The penton was trypsin-sensitive, exerted a cytotoxic effect, and also showed incomplete hemagglutination, being active in the presence of a majority of heterotypic adenovirus antisera studied. (iii) The group-specific hexon antigen reacted in complement fixation reaction and gel precipitation with sera prepared against other types of adenoviruses, besides showing characteristics indicating the presence of a type-specific antigen component. (iv) The soluble complete hemagglutinin was trypsin-sensitive, displayed cytotoxic effect, adsorbed easily to human and rat erythrocytes, and could be eluted from them by means of receptor-destroying enzyme. The three hemagglutinins of adenovirus type 8 proved to be highly unstable, and their demonstration was only successful by using a large quantity of freshly prepared concentrated virus material. Considering these conditions, a method was developed for their concentration and purification.

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELADI I., KAHAN A., KUKAN E., MUCSI I., PAPAI I. AETIOLOGIC RELATIONSHIP OF ADENOVIRUS TYPE 8 TO THE EPIDEMIC OF KERATOCONJUNCTIVITIS IN SZEGED. Acta Microbiol Acad Sci Hung. 1963;10:59–63. [PubMed] [Google Scholar]
  2. Bauer W., Wigand R. Vergleichende Untersuchungen an Hämagglutininen von Adenovirusstämmen der Gruppen I und II. Arch Gesamte Virusforsch. 1967;21(1):11–24. [PubMed] [Google Scholar]
  3. Döhner L. Untersuchungen zum Nachweis von serologischen Unterschieden zwischen den Gruppenantigenen aus verschiedenen Adenovirustypen. I. Herstellung von Adenovirusgruppenantigenen. Z Immunitatsforsch Allerg Klin Immunol. 1968 Nov;136(4):404–414. [PubMed] [Google Scholar]
  4. Gelderblom H., Bauer H., Frank H., Wigand R. The structure of group II adenoviruses. J Gen Virol. 1967 Oct;1(4):553–560. doi: 10.1099/0022-1317-1-4-553. [DOI] [PubMed] [Google Scholar]
  5. Gelderblom H., Meiser W., Lengyel A., Wigand R. The serological relationship of the soluble antigens of adenovirus type 19. J Gen Virol. 1968 May;2(3):331–340. doi: 10.1099/0022-1317-2-3-331. [DOI] [PubMed] [Google Scholar]
  6. HARUNA I., YAOI H., KONO R., WATANABE I. Separation of adenovirus by chromatography on DEAE-Cellulose. Virology. 1961 Feb;13:264–267. doi: 10.1016/0042-6822(61)90065-4. [DOI] [PubMed] [Google Scholar]
  7. JAWETZ E., KIMURA S. J., HANNA L., COLEMAN V. R., THYGESON P., NICHOLAS A. Studies on the etiology of epidemic keratoconjunctivitis. Am J Ophthalmol. 1955 Nov;40(5 Pt 2):200-9; discussion, 209-11. doi: 10.1016/0002-9394(55)91856-0. [DOI] [PubMed] [Google Scholar]
  8. KASEL J. A., ROWE W. P., NEMES J. L. Modification of erythrocyte receptors by a factor in adenovirus suspensions. Virology. 1960 Mar;10:388–391. doi: 10.1016/0042-6822(60)90035-0. [DOI] [PubMed] [Google Scholar]
  9. KJELLEN L. A study of adenovirus-host cell system by the plaque technique. Virology. 1961 Jun;14:234–239. doi: 10.1016/0042-6822(61)90198-2. [DOI] [PubMed] [Google Scholar]
  10. Kjellén L., Pereira H. G. Role of adenovirus antigens in the induction of virus neutralizing antibody. J Gen Virol. 1968 Jan;2(1):177–185. doi: 10.1099/0022-1317-2-1-177. [DOI] [PubMed] [Google Scholar]
  11. LENGYEL A., NASZ I. ADENOVIRUS HAEMAGGLUTINATION-INHIBITING ANTIBODIES IN HUMAN SERA. Acta Microbiol Acad Sci Hung. 1964;11:105–113. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. Lengyel A., Dán P., Cserba I., Nász I. Die wechselseitige heterotypische Hämmagglutinations-Hemmungsreaktion mit Adenoviren Typ 8, 9 und 10. Z Immunitatsforsch Allerg Klin Immunol. 1965 Jul;129(1):34–41. [PubMed] [Google Scholar]
  14. Levine A. J., Ginsberg H. S. Role of adenovirus structural proteins in the cessation of host-cell biosynthetic functions. J Virol. 1968 May;2(5):430–439. doi: 10.1128/jvi.2.5.430-439.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. NASZ I., KULCSAR G., DAN P., LENGYEL A., CSERBA I. STUDIES ON THE AETIOLOGY OF EPIDEMIC KERATOCONJUNCTIVITIS OBSERVED IN BUDAPEST DURING WINTER, 1961--1962. Acta Microbiol Acad Sci Hung. 1963;10:35–40. [PubMed] [Google Scholar]
  16. NASZ I., LENGYEL A., DAN P., KULCSAR G. HETEROTYPIC HAEMAGGLUTINATION INHIBITION IN THE ADENOVIRUS GROUP. Acta Microbiol Acad Sci Hung. 1963;10:379–385. [PubMed] [Google Scholar]
  17. NASZ I. SOME BIOLOGICAL CHARACTERISTICS OF ADENOVIRUS TYPE 8 STRAINS. Acta Microbiol Acad Sci Hung. 1963;10:355–363. [PubMed] [Google Scholar]
  18. Norby E. Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15. J Virol. 1968 Oct;2(10):1200–1210. doi: 10.1128/jvi.2.10.1200-1210.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Norrby E. Biological significance of structural adenovirus components. Curr Top Microbiol Immunol. 1968;43:1–43. doi: 10.1007/978-3-642-46118-7_1. [DOI] [PubMed] [Google Scholar]
  20. Norrby E. Identification of soluble components of adenovirus type 11. J Gen Virol. 1968 Jan;2(1):123–133. doi: 10.1099/0022-1317-2-1-123. [DOI] [PubMed] [Google Scholar]
  21. Norrby E., Skaaret P. Comparison between soluble components of adenovirus types 3 and 16 and of the intermediate strain 3-16 (the San Carlos agent). Virology. 1968 Oct;36(2):201–211. doi: 10.1016/0042-6822(68)90137-2. [DOI] [PubMed] [Google Scholar]
  22. Norrby E. The structural and functional diversity of Adenovirus capsid components. J Gen Virol. 1969 Sep;5(2):221–236. doi: 10.1099/0022-1317-5-2-221. [DOI] [PubMed] [Google Scholar]
  23. PEREIRA H. G., DE FIGUEIREDO M. V. Mechanism of hemagglutination by adenovirus types 1,2,4,5 and 6. Virology. 1962 Sep;18:1–8. doi: 10.1016/0042-6822(62)90171-x. [DOI] [PubMed] [Google Scholar]
  24. PEREIRA H. G. Typing of adenoidal-pharyngeal-conjunctival (APC) viruses by complement-fixation. J Pathol Bacteriol. 1956 Jul;72(1):105–109. [PubMed] [Google Scholar]
  25. Pettersson U., Philipson L., Höglund S. Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology. 1967 Dec;33(4):575–590. doi: 10.1016/0042-6822(67)90057-8. [DOI] [PubMed] [Google Scholar]
  26. Piña M., Green M. Biochemical studies on adenovirus multiplication. IX. Chemical and base composition analysis of 28 human adenoviruses. Proc Natl Acad Sci U S A. 1965 Aug;54(2):547–551. doi: 10.1073/pnas.54.2.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Pusztai R., Béládi I., Bakay M., Mucsi I. Effect of ultraviolet irradiation and heating on the interferon-inducing capacity of human adenoviruses. J Gen Virol. 1969 Mar;4(2):169–176. doi: 10.1099/0022-1317-4-2-169. [DOI] [PubMed] [Google Scholar]
  28. ROSEN L. A hemagglutination-inhibition technique for typing adenoviruses. Am J Hyg. 1960 Jan;71:120–128. doi: 10.1093/oxfordjournals.aje.a120085. [DOI] [PubMed] [Google Scholar]
  29. TAKATSY G. The use of spiral loops in serological and virological micro-methods. Acta Microbiol Acad Sci Hung. 1955;3(1-2):191–202. [PubMed] [Google Scholar]
  30. Trentin J. J., Van Hoosier G. L., Jr, Samper L. The oncogenicity of human adenoviruses in hamsters. Proc Soc Exp Biol Med. 1968 Mar;127(3):683–689. doi: 10.3181/00379727-127-32773. [DOI] [PubMed] [Google Scholar]
  31. Valentine R. C., Pereira H. G. Antigens and structure of the adenovirus. J Mol Biol. 1965 Aug;13(1):13–20. doi: 10.1016/s0022-2836(65)80076-6. [DOI] [PubMed] [Google Scholar]
  32. WILCOX W. C., GINSBERG H. S. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS. Proc Soc Exp Biol Med. 1963 Oct;114:37–42. doi: 10.3181/00379727-114-28579. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES